Company intelligence / Profile preview

Trium Clinical Consulting

Mechelen, Belgium

Ownership: Private
Development stage: Other

Overview

Trium Clinical Consulting is a Belgian-based clinical research organization (CRO) providing specialized services to the pharmaceutical, biotechnology, and medical device sectors. Established in 2004, the firm offers expertise in clinical trial management, regulatory affairs, and quality assurance for Phase I through IV studies. In 2011, Trium was acquired by SGS, a global leader in testing and certification, to bolster its life sciences clinical research capabilities. The company continues to operate as part of the SGS Health Science division, focusing on delivering high-quality clinical development solutions and regulatory compliance support.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Trium Clinical Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trium Clinical Consulting.

Explore the full profile